Malignant Genitourinary System Neoplasm

Observed

← altered in cohorts of

GLB1

450 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

PLXNB1

450 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

ATRIP

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

CCDC51

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

CDC25A

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

CELSR3

449 / 536 cases (84 %) · ssm · TCGA-KIRC · largest of 2 cohorts

—

Observed

← altered in cohorts of

FBXW12

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

HHATL

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

IP6K2

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

NCKIPSD

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

PFKFB4

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

PRKAR2A

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

PTH1R

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

← altered in cohorts of

SCN5A

449 / 536 cases (84 %) · ssm · TCGA-KIRC

—

Observed

Malignant Genitourinary System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 345show all (up to 200)
→ investigated in trials for	Paclitaxelsmall molecule 485 trials (106 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	485	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 445 trials (109 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	445	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 372 trials (93 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	372	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 346 trials (171 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	346	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 321 trials (63 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	321	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 278 trials (85 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	278	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 250 trials (64 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	250	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 208 trials (87 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	208	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzalutamidesmall molecule 204 trials (70 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	204	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisonesmall molecule 194 trials (46 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	194	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 150 trials (40 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	150	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 145 trials (28 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	145	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 143 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	143	Observed	clinicaltrials	graph →
→ investigated in trials for	Leuprolideother 130 trials (29 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	130	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 123 trials (55 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	123	Observed	clinicaltrials	graph →
→ investigated in trials for	Bicalutamidesmall molecule 108 trials (18 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	108	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 108 trials (43 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	108	Observed	clinicaltrials	graph →
→ investigated in trials for	Abiraterone Acetatesmall molecule 107 trials (39 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	107	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 106 trials (14 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	106	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 100 trials (37 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	100	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 97 trials (48 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	97	Observed	clinicaltrials	graph →
→ investigated in trials for	Goserelinother 96 trials (16 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	96	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 90 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	90	Observed	clinicaltrials	graph →
→ investigated in trials for	Degarelixother 87 trials (20 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	87	Observed	clinicaltrials	graph →
→ investigated in trials for	Abirateronesmall molecule 80 trials (32 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	80	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 78 trials (26 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	78	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 72 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	72	Observed	clinicaltrials	graph →
→ investigated in trials for	Apalutamidesmall molecule 71 trials (33 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	71	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 71 trials (25 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	71	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 70 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	70	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 68 trials (23 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	68	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 65 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	65	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 65 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	65	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall molecule 64 trials (23 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	64	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 63 trials (25 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	63	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 58 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	58	Observed	clinicaltrials	graph →
→ investigated in trials for	Darolutamidesmall molecule 57 trials (40 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	57	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 53 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	53	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 53 trials (30 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	53	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 51 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Metforminsmall molecule 51 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	51	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 50 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	50	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 46 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	46	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 45 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	45	Observed	clinicaltrials	graph →
→ investigated in trials for	Flutamidesmall molecule 43 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	43	Observed	clinicaltrials	graph →
→ investigated in trials for	Enfortumab Vedotinadc 40 trials (36 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Estramustinesmall molecule 40 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 40 trials (14 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Zoledronic Acidsmall molecule 40 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	40	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 38 trials (8 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	38	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 36 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	36	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 34 trials (14 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Triptorelinother 34 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	34	Observed	clinicaltrials	graph →
→ investigated in trials for	Relugolixsmall molecule 33 trials (17 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	33	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitomycinsmall molecule 32 trials (13 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Toripalimabmonoclonal antibody 32 trials (26 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Lutetium (177lu) Vipivotide Tetraxetanother 31 trials (21 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor 30 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 30 trials (8 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	30	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 29 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 29 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 29 trials (8 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	29	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 28 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 28 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 28 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall molecule 28 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	28	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 27 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 27 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 26 trials (17 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 26 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 26 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Belzutifansmall molecule 25 trials (20 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	25	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall molecule 25 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	25	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 24 trials (12 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 24 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinblastinesmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 21 trials (15 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 21 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 21 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 21 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 21 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	21	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 19 trials (12 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Mirvetuximab Soravtansineadc 19 trials (10 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 19 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Sacituzumab Govitecanadc 18 trials (13 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	18	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Tivozanibsmall molecule 17 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Megestrolsmall molecule 16 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Prednisolonesmall molecule 16 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 16 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Tamoxifensmall molecule 16 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	16	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Paclitaxel Regimen 15 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Thalidomidesmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinorelbinesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Camrelizumabmonoclonal antibody 14 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Imatinib Mesylatesmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 13 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 13 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody 13 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 12 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Epirubicinsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Sintilimabmonoclonal antibody 12 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Disitamab Vedotinadc 11 trials (9 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Hydroxychloroquinesmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Vincristinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Bleomycin 10 trials (5 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Buparlisibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Denosumabmonoclonal antibody 10 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 10 trials (7 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Nilutamidesmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Thiotepasmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Tisotumab Vedotinadc 10 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Vandetanibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Afliberceptother 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyproterone Acetatesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Erdafitinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Hormone Therapy 9 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Nimotuzumabmonoclonal antibody 9 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Vinfluninesmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Adebrelimabmonoclonal antibody 8 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Exemestanesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Immunotherapy 8 trials (6 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumab/Nivolumab Regimen 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Nintedanibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Retifanlimabmonoclonal antibody 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Romidepsinother 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Trabectedinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumab Emtansineadc 8 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Adjuvant Chemotherapy 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzastaurinsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Imiquimodsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Panobinostatsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Ramucirumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Regorafenibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Serplulimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Tazemetostatsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Alemtuzumabmonoclonal antibody 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Arsenic Trioxidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Buserelinother 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Histrelinother 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Neratinibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Ridaforolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Afatinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Alpelisibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Anastrozolesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Bacillus Calmette-Guerin BCG 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Berzosertibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Dactinomycinother 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Dovitinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Fruquintinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Guadecitabinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemigatinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Perifosinesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Sonidegibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Therapeutic Tumor Infiltrating Lymphocytes 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Valrubicinsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Carmustinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Catumaxomabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Cytarabinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Dordavipronesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Hyperthermic Intraperitoneal Chemotherapy 4 trials (3 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Ibrutinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Inavolisibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Infigratinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Lifileucelcell therapy 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Lurbinectedinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Mercaptopurinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Pasireotideother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Savolitinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Selumetinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Tanespimycinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Malignant Genitourinary System Neoplasm	4	Observed	clinicaltrials	graph →

Malignant Genitourinary System Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 345show all (up to 200)

→ investigated in trials for

Paclitaxelsmall molecule

485 trials (106 active) · roll-up of the cancer and its descendants

—

485

Observed

→ investigated in trials for

Carboplatinsmall molecule

445 trials (109 active) · roll-up of the cancer and its descendants

—

445

Observed

→ investigated in trials for

Cisplatinsmall molecule

372 trials (93 active) · roll-up of the cancer and its descendants

—

372

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

346 trials (171 active) · roll-up of the cancer and its descendants

—

346

Observed

→ investigated in trials for

Docetaxelsmall molecule

321 trials (63 active) · roll-up of the cancer and its descendants

—

321

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

278 trials (85 active) · roll-up of the cancer and its descendants

—

278

Observed

→ investigated in trials for

Gemcitabinesmall molecule

250 trials (64 active) · roll-up of the cancer and its descendants

—

250

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

208 trials (87 active) · roll-up of the cancer and its descendants

—

208

Observed

→ investigated in trials for

Enzalutamidesmall molecule

204 trials (70 active) · roll-up of the cancer and its descendants

—

204

Observed

→ investigated in trials for

Prednisonesmall molecule

194 trials (46 active) · roll-up of the cancer and its descendants

—

194

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

150 trials (40 active) · roll-up of the cancer and its descendants

—

150

Observed

→ investigated in trials for

Doxorubicinsmall molecule

145 trials (28 active) · roll-up of the cancer and its descendants

—

145

Observed

→ investigated in trials for

Sunitinibsmall molecule

143 trials (10 active) · roll-up of the cancer and its descendants

—

143

Observed

→ investigated in trials for

Leuprolideother

130 trials (29 active) · roll-up of the cancer and its descendants

—

130

Observed

→ investigated in trials for

Olaparibsmall molecule

123 trials (55 active) · roll-up of the cancer and its descendants

—

123

Observed

→ investigated in trials for

Bicalutamidesmall molecule

108 trials (18 active) · roll-up of the cancer and its descendants

—

108

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

108 trials (43 active) · roll-up of the cancer and its descendants

—

108

Observed

→ investigated in trials for

Abiraterone Acetatesmall molecule

107 trials (39 active) · roll-up of the cancer and its descendants

—

107

Observed

→ investigated in trials for

Topotecansmall molecule

106 trials (14 active) · roll-up of the cancer and its descendants

—

106

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

100 trials (37 active) · roll-up of the cancer and its descendants

—

100

Observed

→ investigated in trials for

Cabozantinibsmall molecule

97 trials (48 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Goserelinother

96 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

90 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Degarelixother

87 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abirateronesmall molecule

80 trials (32 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

78 trials (26 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

72 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Apalutamidesmall molecule

71 trials (33 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

71 trials (25 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

70 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

68 trials (23 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

65 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

65 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axitinibsmall molecule

64 trials (23 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

63 trials (25 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

58 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Darolutamidesmall molecule

57 trials (40 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

53 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

53 trials (30 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

51 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

51 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

50 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

46 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

45 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Flutamidesmall molecule

43 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

40 trials (36 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Estramustinesmall molecule

40 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

40 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

40 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

38 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

36 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

34 trials (14 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Triptorelinother

34 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Relugolixsmall molecule

33 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall molecule

32 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

32 trials (26 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Vipivotide Tetraxetanother

31 trials (21 active) · roll-up of the cancer and its descendants

—

Observed

Autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor

→ investigated in trials for

30 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

30 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

29 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

29 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

29 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

28 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

28 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

28 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitoxantronesmall molecule

28 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

27 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

27 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

26 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

26 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

26 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belzutifansmall molecule

25 trials (20 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methotrexatesmall molecule

25 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

24 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

24 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

23 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinblastinesmall molecule

23 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

21 trials (15 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

21 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

21 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

21 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

21 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

19 trials (12 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mirvetuximab Soravtansineadc

19 trials (10 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

19 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sacituzumab Govitecanadc

18 trials (13 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gefitinibsmall molecule

17 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

17 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tivozanibsmall molecule

17 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

16 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Megestrolsmall molecule

16 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Prednisolonesmall molecule

16 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

16 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

16 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

16 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

15 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Paclitaxel Regimen

→ investigated in trials for

15 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

15 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall molecule

15 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thalidomidesmall molecule

15 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinorelbinesmall molecule

15 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal antibody

14 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

14 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

13 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

13 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imatinib Mesylatesmall molecule

13 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

13 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

13 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rituximabmonoclonal antibody

13 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

12 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

12 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Epirubicinsmall molecule

12 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal antibody

12 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Disitamab Vedotinadc

11 trials (9 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hydroxychloroquinesmall molecule

11 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

11 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vincristinesmall molecule

11 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bleomycin

10 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buparlisibsmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

10 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

10 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Denosumabmonoclonal antibody

10 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

10 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nilutamidesmall molecule

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Thiotepasmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tisotumab Vedotinadc

10 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vandetanibsmall molecule

10 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

10 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afliberceptother

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyproterone Acetatesmall molecule

9 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erdafitinibsmall molecule

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hormone Therapy

9 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nimotuzumabmonoclonal antibody

9 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vinfluninesmall molecule

9 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adebrelimabmonoclonal antibody

8 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Exemestanesmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Immunotherapy

8 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

Ipilimumab/Nivolumab Regimen

→ investigated in trials for

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nintedanibsmall molecule

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Retifanlimabmonoclonal antibody

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trabectedinsmall molecule

8 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumab Emtansineadc

8 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adjuvant Chemotherapy

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Busulfansmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzastaurinsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall molecule

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panobinostatsmall molecule

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ramucirumabmonoclonal antibody

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Regorafenibsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Serplulimabmonoclonal antibody

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tazemetostatsmall molecule

7 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

7 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Arsenic Trioxidesmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Azacitidinesmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Buserelinother

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Histrelinother

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Neratinibsmall molecule

6 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ridaforolimussmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afatinibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alpelisibsmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alvocidibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Bacillus Calmette-Guerin BCG

→ investigated in trials for

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bendamustinesmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Berzosertibsmall molecule

5 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dactinomycinother

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dovitinibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fruquintinibsmall molecule

5 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Guadecitabinesmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemigatinibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Perifosinesmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sonidegibsmall molecule

5 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Therapeutic Tumor Infiltrating Lymphocytes

→ investigated in trials for

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Valrubicinsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carmustinesmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Catumaxomabmonoclonal antibody

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cytarabinesmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dordavipronesmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

Hyperthermic Intraperitoneal Chemotherapy

→ investigated in trials for

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ibrutinibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Inavolisibsmall molecule

4 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Infigratinibsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lifileucelcell therapy

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lurbinectedinsmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mercaptopurinesmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pasireotideother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Savolitinibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selumetinibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tanespimycinsmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Malignant Prostate Neoplasm

Malignant Genitourinary System Neoplasm studied in …STUDIED_INderived10 of 14,362show all (up to 200)
→ studied in	NCT01230866Phase 3 · active not recruiting Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01242072Phase 1 · completed Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)	—	—	Malignant Ovarian Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01492972Phase 3 · recruiting Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)	—	—	Malignant Prostate Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)	—	—	Fallopian Tube Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)	—	—	Fallopian Tube Clear Cell Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)	—	—	Cervical Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)	—	—	Fallopian Tube Clear Cell Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02613819Phase 2 · completed Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)	—	—	Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)	—	—	Malignant Uterine Corpus Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)	—	—	Malignant Genitourinary System Neoplasm	1	Observed	clinicaltrials	graph →

Malignant Genitourinary System Neoplasm studied in …STUDIED_INderived10 of 14,362show all (up to 200)

→ studied in

NCT01230866Phase 3 · active not recruiting

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)

—

Observed

Malignant Ovarian Neoplasm

→ studied in

NCT01242072Phase 1 · completed

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)

—

Observed

Malignant Prostate Neoplasm

→ studied in

NCT01492972Phase 3 · recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 14,362 trials mapped (4,138 active)

—

Observed

→ studied in

NCT02345265Phase 2 · active not recruiting

Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)

—

Fallopian Tube Carcinoma

Observed

Fallopian Tube Clear Cell Adenocarcinoma

→ studied in

NCT02446600Phase 3 · active not recruiting

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)

—

Observed

→ studied in

NCT02465060Phase 2 · active not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)

—

Cervical Carcinoma

Observed

Fallopian Tube Clear Cell Adenocarcinoma

→ studied in

NCT02502266Phase 2/Phase 3 · active not recruiting

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 14,362 trials mapped (4,138 active)

—

Observed

→ studied in

NCT02613819Phase 2 · completed

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)

—

Renal Cell Carcinoma

Observed

Malignant Uterine Corpus Neoplasm

→ studied in

NCT03348631Phase 2 · active not recruiting

Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)

—

Observed

→ studied in

NCT03866382Phase 2 · recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 14,362 trials mapped (4,138 active)

—

Observed